The mechanism of action is that it affects the production of NAD+ on an intracellular level (Neelakantan, 2019)
FSP1 reduces CoQ10 to CoQH2 [79,80,81], while also engaging in vitamin K reduction and promoting membrane repair, collectively mediating its anti-ferroptotic activity in cancer cells [82,83,84]
The combination of apatinib and ICIs demonstrated favorable therapeutic effects and a manageable safety profile in patients with advanced TNBC
Handgraaf S, Dusaulcy R, Visentin F, Philippe J, Gosmain Y
These may include medications with active ingredients such as semaglutide, tirzepatide, liraglutide, setmelanotide, phentermine, orlistat, and naltrexone-bupropion
Li, M., Hromowyk, K